Tirzepatide may be preferable if you require more aggressive metabolic support, have plateaued on other medications, or show genetic predisposition toward GIP-pathway responsiveness
Tirzepatide produced a significantly greater reduction in HbA1c compared to other OMMs, whereas liraglutide and semaglutide were associated with a greater reduction of FPG in contrast to the other OMMs (Table 1)
This common side effect can turn a positive health milestone into a daily frustration
When the Emotional Cost Gets Real, Behavior Shifts Follow
Now, basically, everyones coming to the middle and asking, How do we responsibly cover these drugs? Part of responsible coverage, Inkinen said, is providing other forms of support to patients who stop using GLP-1 medications, by choice or otherwise